Dr. Carol Dahl directs the Bill & Melinda Gates Foundation’s Global Health Discovery program, which makes grants to achieve fundamental scientific and technological advances in global health that could lead to new ways to prevent, treat, and diagnose disease.
Prior to joining the foundation in 2003, Dahl served as vice president for strategic partnerships at Biospect, Inc., a company developing technology to inform the diagnosis and clinical management of patient health. From 1990 to 2001, Dahl worked in several capacities at the U.S. National Institutes of Health. In 1998, she guided the creation of the Office of Technology and Industrial Relations at the National Cancer Institute (NCI) and served as its first director through 2001.
Previously, she served as Assistant to the Director of NCI, advising on technology development opportunities in support of the National Cancer Program, and as Program Director for the Sequencing Technology Branch at the National Center for Human Genome Research. Dahl also supported the development of the biotechnology portfolio of the Advanced Technology Program of the National Institutes of Standards and Technology. Throughout her tenure in government, Dahl received numerous awards for her work stimulating innovative technologies including, DNA sequencing technology, bioengineering, bioimaging, and nanotechnology, as well as contributing to the launch of critical genomics resources such as the Tumor Gene Index.
Dahl received a bachelor’s degree from the University of Iowa, and master’s and doctoral degrees from the University of Wisconsin-Madison. She received postdoctoral training at the Karolinska Institute in Stockholm and the Immunobiology Research Center at the University of Minnesota, and served on the faculty of the Pittsburgh Cancer Institute.